My thought on $ADXS
I have been looking for ADXS action lately. Good swings if you have stomach for it.
Near-term target $1.20
Long term
The company has cash into 2022.
A few catalysts
Forthcoming Milestones
*ADXS-503: Phase 1/2 combination with KEYTRUDA--clinical and immune/biomarker data for KEYTRUDA failures as well as first-line patients
ADXS-504: Clinical trial initiation; initial data readout
ADXS-PSA: Announcement of next steps
The first patient dosed with HOT-Prostate by Q1 2021
Near-term target $1.20
Long term
The company has cash into 2022.
A few catalysts
- ADXS-HOT: Off-the-shelf, tumor type-specific constructs
ADXS-503 in NSCLC in Phase 1/2 study
ADXS-504 in prostate cancer scheduled to enter the clinic in Q1 2021
Forthcoming Milestones
*ADXS-503: Phase 1/2 combination with KEYTRUDA--clinical and immune/biomarker data for KEYTRUDA failures as well as first-line patients
ADXS-504: Clinical trial initiation; initial data readout
ADXS-PSA: Announcement of next steps
The first patient dosed with HOT-Prostate by Q1 2021
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.